NCT02685943

A Randomized Trial for Suicidal Patients

Completed NA Last updated 19 April 2021

What this trial tests

NA trial testing Psychotherapy in Suicidal Ideation in 80 participants. Completed in 1 October 2019.

Timeline

1 April 2015

Primary endpoint
1 April 2019

1 October 2019

Quick facts

Lead sponsor	Vestre Viken Hospital Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	80
Start date	1 April 2015
Primary completion	1 April 2019
Estimated completion	1 October 2019
Sites	1 location across Norway

Drugs / interventions tested

• Psychotherapy

Conditions studied

• Suicidal Ideation — all drugs for Suicidal Ideation →
• Attempted Suicide — all drugs for Attempted Suicide →
• Suicide — all drugs for Suicide →

Sponsor

Vestre Viken Hospital Trust

Who can join

18 Months and older, any sex, with Suicidal Ideation or Attempted Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although suicide risk is highly prevalent among the patient population in mental health care, remarkably little research exists on effective treatments. Among a small set of novel approaches, CAMS is particularly promising. The investigators compare CAMS to TAU in a randomized controlled trial at four departments in Vestre Viken Hospital Trust, hypothesizing CAMS to be the superior approach. Primary outcome measures are suicidal ideation and suicide attempts, with secondary outcome measures including general symptoms of mental health problems. Changes in the outcome measures are compared between the two groups from baseline to 6 and 12 months after patients are included in the study. The study has the potential to impact the science of treating suicidal individuals and it could benefit the general public by establishing CAMS as an effective clinical approach for rapidly reducing suicide risk.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Psychological therapies for people with borderline personality disorder.
   Storebø OJ, Stoffers-Winterling JM, Völlm BA, Kongerslev MT, et al · · 2020 · cited 208× · PMID 32368793 · DOI 10.1002/14651858.cd012955.pub2
2. Collaborative Assessment and Management of Suicidality (CAMS) compared to treatment as usual (TAU) for suicidal patients: study protocol for a randomized controlled trial.
   Ryberg W, Fosse R, Zahl PH, Brorson I, et al · · 2016 · cited 7× · PMID 27716298 · DOI 10.1186/s13063-016-1602-z